文献速递心律失常

房颤消融术中ICE与TEE比较:一项随机临床试验

Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2025-01-01

该多中心随机试验纳入1810例拟行导管消融的房颤患者,比较心腔内超声(ICE)与经食管超声(TEE)筛查血栓的疗效。结果显示ICE在预防围术期血栓栓塞事件方面不劣于TEE,且减少了穿刺相关大出血、透视时间、术前等待时间和焦虑抑郁发生率。

要点

  • ICE缩短透视时间和术前等待时间,并降低焦虑抑郁发生率。

核心结论

  • 在房颤导管消融术前血栓筛查中,ICE预防围术期血栓栓塞事件不劣于TEE,并在安全性、效率和患者舒适度方面具有额外优势。

研究设计与样本

  • 多中心随机临床试验,中国10家医院,2022年8月至2023年7月纳入1810例成人房颤患者,随机分为ICE组(n=906)和TEE组(n=904),随访30天。

临床怎么用

  • ICE可作为房颤消融术前血栓筛查的替代选择,尤其适用于希望减少TEE相关风险、缩短术前等待和改善舒适度的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Transesophageal echocardiography (TEE) is the standard imaging modality for thrombus screening prior to atrial fibrillation (AF) ablation but carries procedural risks. Intracardiac echocardiography (ICE) is an alternative that may offer comparable safety with procedural advantages. OBJECTIVE: To determine whether ICE is noninferior to TEE in preventing periprocedural thromboembolic events in AF ablation. DESIGN, SETTING, AND PARTICIPANTS: This multicenter randomized clinical trial was conducted at 10 hospitals in China from August 2022 to July 2023, with a 30-day follow-up, enrolling adults with AF scheduled for catheter ablation who met predefined eligibility criteria. Data analysis was performed from August 2023 to December 2023. INTERVENTIONS: Thrombus screening with ICE or TEE prior to ablation. MAIN OUTCOMES AND MEASURES: The primary end point was the incidence of periprocedural thromboembolic events (stroke, transient ischemic attack, or systemic embolism). Secondary end points included thrombus detection, procedural safety and efficiency, and patient-reported comfort. RESULTS: A total of 1810 patients (mean [SD] age, 64.3 [9.4] years; 868 women [48.0%]; 887 patients [49.0%] with paroxysmal AF) were randomized to ICE (n = 906) or TEE (n = 904). Thromboembolic events occurred in 4 of 906 patients undergoing ICE (0.4%) and 5 of 904 patients undergoing TEE (0.6%) (risk difference, -0.11%; Farrington-Manning 95% CI, -0.84% to 0.62%; P for noninferiority = .01). Thrombus was detected in 2.0% vs 1.5% (relative risk [RR], 1.29; 95% CI, 0.64-2.61; P = .48) with ICE vs TEE, respectively, with more non-left atrial appendage thrombi in ICE (0.6% vs 0%; P < .001). Major bleeding related to transseptal puncture was lower with ICE (0.2% vs 1.2%; RR, 0.18; 95% CI, 0.04-0.81; P = .03). ICE reduced mean (SD) fluoroscopy time (4.2 [1.5] vs 9.3 [3.0] minutes; P < .001), preprocedural waiting time (14.4 [8.0] vs 23.6 [10.5] hours; P < .001), and anxiety or depression prevalence (24.6% vs 37.5%; RR, 0.66; 95% CI, 0.56-0.76; P < .001). CONCLUSIONS AND RELEVANCE: In this multicenter randomized clinical trial, ICE was noninferior to TEE for preventing thromboembolic complications in AF ablation and offered additional advantages in safety, efficiency, and patient comfort, supporting its use as a viable alternative in clinical practice. TRIAL REGISTRATION: ClinicalTrial.gov Identifier: NCT05466266.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Hu, Jiang, Wang, et al. Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial. JAMA Cardiol. 2025. PMID: 41060665. doi:10.1001/jamacardio.2025.3687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。